We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

601567:SSENingbo Sanxing Medical Electric Co., Ltd. Class A Analysis

Data as of 2026-09-14 - not real-time

CN¥13.59

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

The moving-average structure behind Ningbo Sanxing Medical Electric Co.,Ltd. is bearish at ¥13.59, with short-term averages lagging the long-term ones. Over a rolling month the price has lost 18.5%. With RSI at 40.5 the momentum picture is neutral, alongside a bearish MACD signal. Price has been bracketed by support at ¥12.83 and resistance at ¥15.68.
Multiples put this in fair territory: 32.4 times earnings against the sector's 28.0. Analyst price targets sit 163.2% above the current price. Revenue is contracting at 7.3% on a 4.3% profit margin. The 11.80% dividend yield looks stretched against payout coverage.
The composite risk read is 6/10, putting it in elevated territory. With 30-day volatility of 32.3%, a beta of 0.52 and a maximum drawdown of 60.8%, position sizing matters here. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
Near-term and long-term part ways here — sell short-term against hold longer out, with 2/10 conviction on the long call.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 5/10

Key Factors

  • Short-term moving averages stacked below long-term ones
  • Trading below the 200-day average of 20.67
  • MACD momentum is negative

Medium Term

1–3 years
Neutral
Model confidence: 3/10

Key Factors

  • Short-term moving averages stacked below long-term ones
  • P/E of 32.4 versus sector average of 28.0
  • Dividend yield of 11.80% looks stretched against payout coverage

Long Term

> 3 years
Neutral
Model confidence: 2/10

Key Factors

  • P/E of 32.4 versus sector average of 28.0
  • Dividend yield of 11.80% looks stretched against payout coverage
  • Analyst targets imply +163.2% versus the current price

Key Metrics & Analysis

Financial Health

Revenue Growth-7.30%
Profit Margin4.32%
P/E Ratio32.4
ROE4.76%
ROA1.90%
Debt/Equity30.10
P/B Ratio1.6
Op. Cash FlowCN¥2.0B
Free Cash FlowCN¥744.7M
Industry P/E28.0

Technical Analysis

TrendBearish
RSI40.5
SupportCN¥12.83
ResistanceCN¥15.68
MA 20CN¥14.16
MA 50CN¥14.73
MA 200CN¥20.67
MACDBearish
VolumeIncreasing
Fear & Greed Index93.14

Valuation

Fair ValueCN¥5.86
Target PriceCN¥35.77
Upside/Downside163.18%
GradeFair
TypeBlend
Dividend Yield11.80%

Risk Assessment

Beta0.52
Volatility32.28%
Sector RiskMedium
Reg. RiskMedium
Geo RiskHigh
Currency RiskHigh
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.